Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
暂无分享,去创建一个
M. Moerland | P. Jacqmin | J. Burggraaf | J. Reijers | C. Min | K. D. Graaf | G. Lapeyre | C. Min | E. Monnet | E. V. Poelgeest | E van Poelgeest | K de Graaf | Philippe Jacqmin | Geneviève Lapeyre | Cristina de Min | Joannes A A Reijers